| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$3,599,772 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease | 001 | 4 | NIH | 4/15/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184768 | Circularization of RNA to improve the durability of the vaccine immune response | 000 | 2 | NIH | 5/7/2026 | $798,400 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI187192 | Investigation of RNA packaging in Rift Valley fever virus | 000 | 2 | NIH | 12/5/2025 | $655,774 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG097537 | Microglia and Tau Oligomer Polymorphs Interplay in Cognitive Resilience in Alzheimers disease | 001 | 1 | NIH | 3/4/2026 | $15,375 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG097537 | Microglia and Tau Oligomer Polymorphs Interplay in Cognitive Resilience in Alzheimers disease | 000 | 1 | NIH | 12/23/2025 | $548,723 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 001 | 4 | NIH | 3/2/2026 | $37,057 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 4 | NIH | 1/30/2026 | $333,513 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG083102 | Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias | 000 | 4 | NIH | 4/7/2026 | $544,644 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 000 | 5 | NIH | 3/23/2026 | $748,330 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 000 | 10 | NIH | 3/24/2026 | $757,565 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30DA065327 | Mechanisms of prenatal opioid exposure on offspring brain development and behavior | 001 | 1 | NIH | 3/25/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30DA065327 | Mechanisms of prenatal opioid exposure on offspring brain development and behavior | 000 | 1 | NIH | 2/19/2026 | $39,039 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI197328 | Bacterial histamine production as a novel mechanism of host immune evasion | 001 | 1 | NIH | 4/13/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI197328 | Bacterial histamine production as a novel mechanism of host immune evasion | 000 | 1 | NIH | 3/27/2026 | $42,009 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 5 | NIH | 12/3/2025 | $480,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 5 | NIH | 2/23/2026 | $173,047 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 5 | NIH | 2/23/2026 | $75,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21NS140036 | Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2 | 000 | 2 | NIH | 12/18/2025 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI183177 | Identification of diagnostic biomarkers for flea-borne typhus | 000 | 2 | NIH | 1/10/2026 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03AI182562 | Development of a latex-agglutination assay for the rapid detection of Naegleria fowleri | 000 | 2 | NIH | 12/3/2025 | $80,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 001 | 5 | NIH | 3/19/2026 | $51,604 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 000 | 5 | NIH | 1/28/2026 | $464,451 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS140424 | Sculpting Membrane Dynamics: Membrane-Remodeling Factors Shape Oligodendroglial Form and Function | 001 | 2 | NIH | 3/18/2026 | $45,818 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS140424 | Sculpting Membrane Dynamics: Membrane-Remodeling Factors Shape Oligodendroglial Form and Function | 000 | 2 | NIH | 1/26/2026 | $412,371 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS131507 | The role of neuro-immune interactions in PACAP induced migraine | 000 | 3 | NIH | 2/20/2026 | $499,611 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH077303 | Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges | 000 | 19 | NIH | 12/16/2025 | $737,907 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 4 | NIH | 12/10/2025 | $794,232 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 000 | 3 | NIH | 1/27/2026 | $689,960 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM145925 | Mitochondrial translesion DNA synthesis | 000 | 4 | NIH | 4/17/2026 | $333,746 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 001 | 4 | NIH | 3/10/2026 | $32,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 4 | NIH | 1/29/2026 | $288,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD110408 | Targeting proteinopathy/tauopathy and impaired autophagy for mechanistic understanding and therapeutic intervention of preeclampsia | 000 | 3 | NIH | 4/1/2026 | $485,838 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES037276 | Understanding the role of gut microbiome in trichloroethene-mediated autoimmunity | 000 | 1 | NIH | 3/31/2026 | $718,775 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 002 | 2 | NIH | 2/19/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 001 | 2 | NIH | 1/29/2026 | $571,222 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 4 | NIH | 4/28/2026 | $541,883 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK138055 | Viral-immune interaction in glomerular kidney disease | 000 | 3 | NIH | 3/4/2026 | $613,186 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 4 | NIH | 1/8/2026 | $468,449 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK077148 | Metabolic and xenobiotic control of thyroid hormone metabolism | 000 | 13 | NIH | 2/24/2026 | $423,748 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA053472 | Novel Addiction Neurocircuits in Cocaine Taking | 000 | 5 | NIH | 2/11/2026 | $488,840 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 3 | NIH | 4/8/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA038446 | 5-HT2 Receptor Allosterism in Cocaine Use Disorder | 000 | 10 | NIH | 4/29/2026 | $538,887 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI195888 | Novel Artificial Intelligence approaches to distinguish allergenic from non-allergenic proteins | 000 | 1 | NIH | 2/13/2026 | $429,499 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 5 | NIH | 12/2/2025 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI160226 | Preclinical development of a vaccine for Nipah virus | 000 | 5 | NIH | 1/29/2026 | $1,064,364 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UH3NS128397 | Chronic Subdural Hematoma Treatment with Embolization vs Surgery or MedicalManagement Study (CHESS) | 000 | 3 | NIH | 3/5/2026 | $3,041,130 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 001 | 4 | FDA | 3/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 4 | FDA | 1/28/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 3 | NIH | 1/13/2026 | $275,062 |
|
